Ignite Creation Date:
2024-05-06 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05188885
Status:
RECRUITING
Last Update Posted:
2023-02-23
First Post:
2021-12-22
Brief Title:
A Real World Multi-centric Observational Registry Study of Chronic Kidney Diseases
Sponsor:
Guangdong Provincial Peoples Hospital
Organization:
Guangdong Provincial Peoples Hospital
Study Overview
Official Title:
A Real World Multi-centric Observational Registry Study of Chronic Kidney Diseases
Status:
RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chronic kidney disease CKD refers to a variety of different diseases characterized by impairment of kidney structure andor renal function The prevalence of CKD in China is as high as 108 With a population of more than 150 million China has the largest number of CKD patients all over the world People with CKD would not only progress to uremia and need renal replace treatment it also significantly increases risk of cardiovascular disease than non-CKD population It has created a heavy burden on peoples health and national economy There is an urgent need to establish an effective system for CKD prevention and control in China Evidences from large sample cohort and real world based research are still rare This study will provide good experience for reducing the occurrence and development of CKD
Detailed Description:
This study is designed as an investigator-initiated multi-center prospective and observational real world study based on mainland Chinese population The investigators aimed to investigate the occurrence development treatment prognosis state and related risk factors of CKD in China
This study based on the standardized data network which provides efficient data collection integration and analysis for researchers and clinicians in multi-centers
The sample size of this study was estimated by statisticians epidemiologists and clinicians Real-world studies adopted an open standard for inclusion and exclusion larger sample size could cover a wider group of patients and take the possibility of loss of follow-up into account Subgroup analysis can be performed in a heterogeneous population and expand the significance of the study
This study based on the standardized data network which provides efficient data collection integration and analysis for researchers and clinicians in multi-centers
The sample size of this study was estimated by statisticians epidemiologists and clinicians Real-world studies adopted an open standard for inclusion and exclusion larger sample size could cover a wider group of patients and take the possibility of loss of follow-up into account Subgroup analysis can be performed in a heterogeneous population and expand the significance of the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None